ANXA1 has been shown to be overexpressed in cancers such as lung [91], pancreatic [92] and a number of breast cancer subtypes [93, 94, but contrastingly expressed at lower levels in other types of cancer such as prostate [95] and laryngeal [96, 97. Here, ANXA1 is linked to cancer.